Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : White House plan to allow foreign visitors silent on easing Canada-U.S. restrictions

09/20/2021 | 04:35pm EDT

WASHINGTON — The White House overhauled some of its international travel restrictions Monday, but left in place a controversial ban on travel across the Canada-U.S. land border even as it announced that by early November, it would allow overseas air visitors who are fully vaccinated against COVID-19.

It was the first clear indication in months that President Joe Biden's administration is getting ready to ease and streamline the patchwork of travel restrictions that were first imposed at the outset of the pandemic in March 2020, when Donald Trump was still president.

But the ongoing prohibition on recreational travellers driving from Canada and Mexico — extended now for a 19th month until Oct. 21 — came to some as nothing short of a slap in the face.

"Canadians should be pissed off, and for good reason," said Rep. Brian Higgins, a New York congressman who has been fighting for months to convince the White House to ease the restrictions.

Maintaining the travel ban at the land border undermines the very same public faith in the COVID-19 vaccines that the Biden administration is working so hard to convince Americans to embrace, he added.

"The White House is in conflict with itself, and in conflict with the science that they support and push others to follow," Higgins said in an interview. "Their legitimacy and credibility on this issue has taken a justifiably hard hit. The White House isn't speaking with one voice."

The new rules replace Trump-era travel bans that restricted visits to the U.S. by those who had recently been in the United Kingdom, the European Union, China, India, Iran, Ireland, Brazil and South Africa. Passengers will have to show proof of vaccination before boarding, as well as a negative COVID-19 test taken no more than three days prior to departure.

In that respect, they are similar to the requirements Canada began imposing over the summer — initially on returning Canadians, then on U.S. citizens and permanent residents, then finally earlier this month on all foreign nationals.

Air travel to the U.S. from Canada has never been restricted, and it's not yet clear whether the new vaccination rules will be imposed on Canadian passengers when they take effect. The rules at the Canada-U.S. border have also allowed trade and essential workers to move between the two countries unfettered.

The other burning question is whether Canadians who received the Oxford-AstraZeneca vaccine, which has never been approved for use in the U.S., will meet the eligibility test. Federal officials say they are pressing the Biden administration to ensure those people will be allowed in.

About 3.9 million people in Canada have received a mixed-dose regimen of COVID-19 vaccines, with an estimated 1.4 million of them having received an AstraZeneca dose, Public Health Agency of Canada data indicates. More than 223,000 people are fully vaccinated with AstraZeneca.

"This is all a part of the process," White House press secretary Jen Psaki said Monday when asked about specific vaccine requirements, as well as whether and when the land border restrictions would be amended or eased.

"We don't have any updates or predictions at this point in time, but obviously we are continuing to consider — as is evident by our announcement today — how we can return to a place of travel and people being able to move from country to country, including at our land borders."

More stringent testing and quarantine requirements will also be put in place for unvaccinated travellers when the new rules take effect in November.

The U.S. is clearly more willing to allow people into the country via air than by land — evidence of the importance they place on the ability of airlines to handle the cumbersome chore of screening travellers and ensuring they meet the necessary health requirements.

"It's incredibly frustrating, it confounds logic, and something's got to give," said Scotty Greenwood, president and CEO of the D.C.-based Canadian American Business Council.

"I don't understand the policy rationale for discriminating against Canadians based on their proximity. If we're willing to allow Canadians to fly and we're now willing to allow other nations to fly, why wouldn't we allow Canadians to drive? It doesn't make any sense."

A fresh batch of U.S.Senate Democrats, including Michigan senators Debbie Stabenow and Gary Peters, Sen. Kirsten Gillibrand of New York and New Hampshire Sen. Jeanne Shaheen, wrote Friday to urge Biden to finally lift the ban.

"We believe that fully vaccinated Canadians should be allowed to safely travel into the United States via land ports of entry," reads the letter, which was also signed by New Hampshire Sen. Maggie Hassan, and Minnesota Sen. Amy Klobuchar and Sen. Angus King, the Independent from Maine.

"We urge you to lift these restrictions before October, provide a plan for reopening land ports of entry and appoint an interagency lead on U.S.-Canadian border restrictions related to the COVID-19 pandemic."

Homeland Security Sec. Alejandro Mayorkas, whose department oversees the U.S. border agency, acknowledged the growing frustration during a National Press Club event last week in Washington.

"We had hoped that by now, we would have opened up travel through the ports of entry, but regrettably, because of the Delta variant, we've been delayed in doing so," Mayorkas said.

The restrictions now include language that make it possible to relax or lift the ban entirely before the start of the next 30-day window, he added.

"Because we've renewed it for 30 days does not necessarily mean that the restriction will last for another 30 days."

There's also the U.S.-Mexico border, where an escalating immigration crisis is complicating matters. Mayorkas himself travelled Monday to the south Texas region where upwards of 14,000 migrants from Haiti have been gathering, with more arriving daily, in hopes of winning asylum in the U.S.

"We're only left to speculate about what other unrelated issues may be at work here — is it the southern border? Quite possibly," Higgins said.

"But they should be able to manage both. They're very, very different, with both opportunities and challenges. But the northern border is very, very different from the southern border."

This report by The Canadian Press was first published Sept. 20, 2021.

© 2021 The Canadian Press. All rights reserved., source Canadian Press DataFile

All news about ASTRAZENECA PLC
10/26ASTRAZENECA : Deutsche Bank reiterates its Buy rating
10/26VACCINATED BUT STUCK : Indians await WHO nod for homegrown shot to travel abroad
10/25AstraZeneca PLC Announces Positive High-Level Results from the TOPAZ-1 Phase III Trial
10/25ASTRAZENECA : Daiichi Sankyo in Clinical Trial Collaboration to Evaluate Datopotamab Derux..
10/25WALL STREET STOCK EXCHANGE : 84% of Q3 earnings reports exceed expectations
10/25ANALYST RECOMMENDATIONS : American Express, Beyond Meat, Microsoft, Oracle, Weibo...
10/25UNIVERSITY OF BIRMINGHAM : A third of leukaemia patients do not generate any antibody resp..
10/25ASTRAZENECA : Imfinzi plus chemotherapy significantly improved overall survival in 1st-lin..
10/25ASTRAZENECA : JP Morgan reiterates its Buy rating
10/25ASTRAZENECA : Imfinzi plus chemotherapy significantly improved overall survival in 1st-lin..
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 441 M - -
Net income 2021 4 862 M - -
Net Debt 2021 24 715 M - -
P/E ratio 2021 35,9x
Yield 2021 2,27%
Capitalization 192 B 192 B -
EV / Sales 2021 6,11x
EV / Sales 2022 4,95x
Nbr of Employees 76 100
Free-Float 96,4%
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 27
Last Close Price 123,93 $
Average target price 137,83 $
Spread / Average Target 11,2%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC22.92%192 243
JOHNSON & JOHNSON5.32%431 938
ROCHE HOLDING AG15.61%338 364
NOVO NORDISK A/S59.69%243 351
PFIZER, INC.17.22%241 929